NASDAQ · Biotechnology

AMLX (AMLX) Stock

$33.81 +0.18% NASDAQ: AMLX Healthcare

Valuation

MetricValue
Price$33.81
Market Cap$3.76B
P/E Ratio-8.69
P/B Ratio3.62
P/S Ratio0.00
EPS (TTM)$-1.53
52-Week High$40.62
52-Week Low$4.80
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-47.54%
ROA-43.54%
ROCE-50.00%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.02
Current Ratio14.09

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$22.0M$381.0M$87.0M$0
Operating Profit$-83.0M$-201.0M$39.0M$-315.0M$-153.0M
Net Profit$-88.0M$-198.0M$49.0M$-302.0M$-145.0M
EPS$-1.52$-2.98$0.70$-4.43$-1.53
Op Margin—-905.7%10.2%-360.2%—

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$106.0M$391.0M$517.0M$194.0M$333.0M
Total Liabilities$257.0M$51.0M$84.0M$29.0M$27.0M
Cash$50.0M$63.0M$170.0M$77.0M$227.0M
Borrowings$0$6.0M$4.0M$2.0M$6.0M

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-75.0M$-180.0M$12.0M$-168.0M$-123.0M
Investing Cash Flow$-47.0M$-242.0M$91.0M$75.0M$14.0M
Financing Cash Flow$-2.0M$-1.0M$-3.0M$-2.0M$-3.0M
Net Cash Flow$37.0M$13.0M$108.0M$-92.0M$149.0M
Free Cash Flow$-75.0M$-182.0M$11.0M$-168.0M$-123.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-11.27%
Quick Ratio17.85
Interest Coverage—
Return 1Y268.79%
Return 3Y60.09%
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ATAI $7.34 +0.00% -8.44 $2.72B 0.00%
CVACCureVac N.V. $4.66 +0.00% 5.69 $1.05B 0.00%
IMTX $9.43 -1.05% -4.98 $1.26B 0.00%
INBX $124.66 -1.61% -14.11 $1.83B 0.00%
NKTR $71.75 +0.52% -6.95 $2.06B 0.00%

About AMLX

AMLX is led by CEO Joshua Cohen, employs 123 people, headquartered in US, publicly traded since 2022.

AMLX stock trades at $33.81 with a market capitalization of $3.76B. The stock is valued at a price-to-earnings (P/E) ratio of -8.69, price-to-book of 3.62, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $4.80 and $40.62, and currently trades 16.8% below its 52-week high.

On profitability, AMLX generates a return on equity (ROE) of -47.54%, return on capital employed of -50.00%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1159.93 +0.28% JNJ Drug Manufacturers - General $271.19 +2.01% ABBV Drug Manufacturers - General $259.99 +1.39% MRK Drug Manufacturers - General $149.94 +1.48% UNH Medical - Healthcare Plans $396.30 +1.77% NVS Drug Manufacturers - General $161.25 +6.04% AZN Drug Manufacturers - General $162.47 +0.21% AMGN Drug Manufacturers - General $438.12 +1.92% TMO Medical - Diagnostics & Research $600.50 -2.69% NVO Biotechnology $45.12 -0.46% ABT Medical - Devices $108.97 -1.26% GILD Drug Manufacturers - General $149.92 +2.45%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides